DE69429208D1 - Substanz P Antagonisten zur Behandlung von Erbrechen - Google Patents
Substanz P Antagonisten zur Behandlung von ErbrechenInfo
- Publication number
- DE69429208D1 DE69429208D1 DE69429208T DE69429208T DE69429208D1 DE 69429208 D1 DE69429208 D1 DE 69429208D1 DE 69429208 T DE69429208 T DE 69429208T DE 69429208 T DE69429208 T DE 69429208T DE 69429208 D1 DE69429208 D1 DE 69429208D1
- Authority
- DE
- Germany
- Prior art keywords
- substance
- antagonists used
- treat vomiting
- derivatives
- vomiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/072,629 US5393762A (en) | 1993-06-04 | 1993-06-04 | Pharmaceutical agents for treatment of emesis |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69429208D1 true DE69429208D1 (de) | 2002-01-10 |
DE69429208T2 DE69429208T2 (de) | 2002-05-23 |
Family
ID=22108825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69429208T Expired - Fee Related DE69429208T2 (de) | 1993-06-04 | 1994-05-16 | Substanz P Antagonisten zur Behandlung von Erbrechen |
Country Status (19)
Country | Link |
---|---|
US (1) | US5393762A (de) |
EP (1) | EP0627221B1 (de) |
JP (1) | JP2671972B2 (de) |
KR (1) | KR100190729B1 (de) |
CN (1) | CN1100535C (de) |
AT (1) | ATE209490T1 (de) |
AU (1) | AU666077B2 (de) |
CA (1) | CA2124990C (de) |
DE (1) | DE69429208T2 (de) |
DK (1) | DK0627221T3 (de) |
ES (1) | ES2164088T3 (de) |
HU (1) | HU222243B1 (de) |
IL (1) | IL109802A (de) |
MY (1) | MY115310A (de) |
NZ (1) | NZ260674A (de) |
PT (1) | PT627221E (de) |
RU (1) | RU2135179C1 (de) |
TW (1) | TW318791B (de) |
ZA (1) | ZA943896B (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU657552B2 (en) * | 1991-05-31 | 1995-03-16 | Pfizer Inc. | Quinuclidine as substance P antagonists |
JPH07110850B2 (ja) * | 1991-06-20 | 1995-11-29 | フアイザー・インコーポレイテツド | 窒素含有複素環化合物のフルオロアルコキシベンジルアミノ誘導体 |
EP0533280B2 (de) | 1991-09-20 | 2004-12-01 | Glaxo Group Limited | Neue medizinische Indikation für Tachykinin-Antagonisten |
US6048859A (en) | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
ATE166650T1 (de) * | 1993-03-04 | 1998-06-15 | Pfizer | Spiroazacyclischderivate als substanz p antagonisten |
GB9305718D0 (en) * | 1993-03-19 | 1993-05-05 | Glaxo Group Ltd | Medicaments |
US5576317A (en) * | 1994-12-09 | 1996-11-19 | Pfizer Inc. | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
WO1996030367A1 (fr) * | 1995-03-27 | 1996-10-03 | Hisamitsu Pharmaceutical Co., Inc. | Derives de piperidine |
TW340842B (en) * | 1995-08-24 | 1998-09-21 | Pfizer | Substituted benzylaminopiperidine compounds |
TW458774B (en) * | 1995-10-20 | 2001-10-11 | Pfizer | Antiemetic pharmaceutical compositions |
US6329396B1 (en) | 1996-06-10 | 2001-12-11 | Pfizer Inc. | Substituted benzylaminopiperidine compounds |
GB9708484D0 (en) * | 1997-04-25 | 1997-06-18 | Merck Sharp & Dohme | Therapeutic agents |
US6214846B1 (en) * | 1997-06-27 | 2001-04-10 | Merck Sharp & Dohme Limited | Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
AU1409100A (en) * | 1998-11-27 | 2000-06-19 | Takeda Chemical Industries Ltd. | Drugs |
NZ501211A (en) * | 1999-01-29 | 2001-10-26 | Pfizer Prod Inc | Pharmaceutical composition comprising macrolide antibiotic like erythromycin and a Substance P antagonist, and method for treating cancer, bacterial and protozoal infection in non-humans |
US6255320B1 (en) * | 1999-06-01 | 2001-07-03 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
US6387925B1 (en) * | 1999-06-01 | 2002-05-14 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
US6262067B1 (en) * | 1999-06-22 | 2001-07-17 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions |
IL142810A0 (en) * | 2000-05-03 | 2002-03-10 | Pfizer Prod Inc | Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
SK252004A3 (sk) * | 2001-07-20 | 2005-03-04 | Pfizer Products Inc. | Použitie antagonistov receptora NK-1 na výrobu liečiva na liečenie abnormálneho úzkostného správania domácich zvierat a spôsob screeningu skúšanej zlúčeniny s cieľom stanoviť anxiolytickú účinnosť u psov |
KR100834232B1 (ko) * | 2004-01-30 | 2008-05-30 | 화이자 프로덕츠 인크. | 액체 투여형용 베타-시클로덱스트린을 사용하는 다수회투여 제형을 얻기 위한 항균 방부제 |
BRPI0507325A (pt) * | 2004-01-30 | 2007-07-03 | Pfizer Prod Inc | antagonistas dos receptores nk-1 para melhorar a recuperação da anestesia |
KR100812046B1 (ko) * | 2004-02-02 | 2008-03-10 | 화이자 프로덕츠 인크. | 1-(2s,3s)-2-벤즈히드릴-n-(5-삼급-부틸-2-메톡시벤질)퀴누클리딘-3-아민의 제조 방법 |
WO2014197137A1 (en) * | 2013-04-29 | 2014-12-11 | Howard Brooks-Korn | Diversion-resistant formulation |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8527052D0 (en) * | 1985-11-02 | 1985-12-04 | Beecham Group Plc | Compounds |
WO1990005525A1 (en) * | 1988-11-23 | 1990-05-31 | Pfizer Inc. | Quinuclidine derivatives as substance p antagonists |
US5232929A (en) * | 1990-11-28 | 1993-08-03 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use |
ATE113947T1 (de) * | 1990-06-01 | 1994-11-15 | Pfizer | 3-amino-2-arylchinuclidine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. |
CA2086434C (en) * | 1990-07-23 | 1998-09-22 | John A. Lowe, Iii | Quinuclidine derivatives |
CZ387492A3 (en) * | 1990-09-28 | 1994-02-16 | Pfizer | Analogs of non-aromatic hetero cycles containing nitrogen with a condensed ring, process of their preparation and use |
WO1992012151A1 (en) * | 1991-01-10 | 1992-07-23 | Pfizer Inc. | N-alkyl quinuclidinium salts as substance p antagonists |
EP0573522B1 (de) * | 1991-03-01 | 1994-12-14 | Pfizer Inc. | 1-azabicyclo[3.2.2]nonan-3-aminderivate |
CA2106200C (en) * | 1991-03-26 | 1996-11-19 | Terry J. Rosen | Stereoselective preparation of substituted piperidines |
UA26401C2 (uk) * | 1991-05-22 | 1999-08-30 | Пфайзер Інк. | Заміщеhі 3-аміhохіhуклідиhи |
AU657552B2 (en) * | 1991-05-31 | 1995-03-16 | Pfizer Inc. | Quinuclidine as substance P antagonists |
JPH07110850B2 (ja) * | 1991-06-20 | 1995-11-29 | フアイザー・インコーポレイテツド | 窒素含有複素環化合物のフルオロアルコキシベンジルアミノ誘導体 |
TW202432B (de) * | 1991-06-21 | 1993-03-21 | Pfizer | |
EP0533280B2 (de) * | 1991-09-20 | 2004-12-01 | Glaxo Group Limited | Neue medizinische Indikation für Tachykinin-Antagonisten |
HU9400728D0 (en) * | 1991-09-26 | 1994-06-28 | Pfizer | Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists |
JP2614408B2 (ja) * | 1991-11-12 | 1997-05-28 | ファイザー・インコーポレーテッド | サブスタンスp受容体アンタゴニストとしての非環式エチレンジアミン誘導体 |
JP2656702B2 (ja) * | 1992-03-23 | 1997-09-24 | ファイザー製薬株式会社 | ペプチド性キヌクリジン |
DE69331190T2 (de) * | 1992-05-18 | 2002-04-18 | Pfizer | Überbrückte azabicyclische derivate als substanz p antagonisten |
ES2147759T3 (es) * | 1992-12-10 | 2000-10-01 | Pfizer | Heterociclos no aromaticos sustituidos con aminometileno y uso como antagonistas de la sustancia p. |
ATE166650T1 (de) * | 1993-03-04 | 1998-06-15 | Pfizer | Spiroazacyclischderivate als substanz p antagonisten |
GB9305718D0 (en) * | 1993-03-19 | 1993-05-05 | Glaxo Group Ltd | Medicaments |
WO2000010073A1 (en) * | 1998-08-14 | 2000-02-24 | Via, Inc. | Mobile robotic snake |
-
1993
- 1993-06-04 US US08/072,629 patent/US5393762A/en not_active Expired - Lifetime
-
1994
- 1994-04-12 TW TW083103232A patent/TW318791B/zh active
- 1994-05-16 AT AT94303467T patent/ATE209490T1/de not_active IP Right Cessation
- 1994-05-16 DK DK94303467T patent/DK0627221T3/da active
- 1994-05-16 DE DE69429208T patent/DE69429208T2/de not_active Expired - Fee Related
- 1994-05-16 PT PT94303467T patent/PT627221E/pt unknown
- 1994-05-16 EP EP94303467A patent/EP0627221B1/de not_active Expired - Lifetime
- 1994-05-16 ES ES94303467T patent/ES2164088T3/es not_active Expired - Lifetime
- 1994-05-26 IL IL10980294A patent/IL109802A/en not_active IP Right Cessation
- 1994-06-02 JP JP6121042A patent/JP2671972B2/ja not_active Expired - Fee Related
- 1994-06-02 CA CA002124990A patent/CA2124990C/en not_active Expired - Fee Related
- 1994-06-02 MY MYPI94001422A patent/MY115310A/en unknown
- 1994-06-03 CN CN94106917A patent/CN1100535C/zh not_active Expired - Fee Related
- 1994-06-03 AU AU64521/94A patent/AU666077B2/en not_active Ceased
- 1994-06-03 NZ NZ260674A patent/NZ260674A/en not_active IP Right Cessation
- 1994-06-03 RU RU94020410A patent/RU2135179C1/ru not_active IP Right Cessation
- 1994-06-03 ZA ZA943896A patent/ZA943896B/xx unknown
- 1994-06-03 KR KR1019940012527A patent/KR100190729B1/ko not_active IP Right Cessation
- 1994-06-03 HU HU9401676A patent/HU222243B1/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1100535C (zh) | 2003-02-05 |
AU666077B2 (en) | 1996-01-25 |
HU222243B1 (hu) | 2003-05-28 |
EP0627221A2 (de) | 1994-12-07 |
EP0627221B1 (de) | 2001-11-28 |
DE69429208T2 (de) | 2002-05-23 |
DK0627221T3 (da) | 2002-02-11 |
KR950000144A (ko) | 1995-01-03 |
NZ260674A (en) | 2000-07-28 |
CN1121806A (zh) | 1996-05-08 |
IL109802A0 (en) | 1994-08-26 |
PT627221E (pt) | 2002-04-29 |
TW318791B (de) | 1997-11-01 |
JPH0753362A (ja) | 1995-02-28 |
ATE209490T1 (de) | 2001-12-15 |
MY115310A (en) | 2003-05-31 |
US5393762A (en) | 1995-02-28 |
KR100190729B1 (ko) | 1999-06-01 |
HUT71550A (en) | 1995-12-28 |
EP0627221A3 (de) | 1995-08-02 |
ZA943896B (en) | 1995-12-04 |
RU94020410A (ru) | 1996-05-10 |
CA2124990C (en) | 1999-04-20 |
RU2135179C1 (ru) | 1999-08-27 |
IL109802A (en) | 2002-04-21 |
HU9401676D0 (en) | 1994-09-28 |
AU6452194A (en) | 1994-12-15 |
ES2164088T3 (es) | 2002-02-16 |
JP2671972B2 (ja) | 1997-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69429208D1 (de) | Substanz P Antagonisten zur Behandlung von Erbrechen | |
DE69429299D1 (de) | Verwendung von Tachykinin-Antagonisten zur Behandlung von Erbrechen | |
ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
GB9406857D0 (en) | Improvements in or relating to organic compounds | |
ES2153076T3 (es) | Agentes herbicidas basados en bencisoxazol y bencisotiazol sustituidos. | |
DK0701546T3 (da) | Aromatiske acetylchlolinesteraseinhibitorer | |
ES2104358T3 (es) | Inhibidores sililados de acetilcolinesterasa. | |
ES2150418T3 (es) | Composiciones farmaceuticas que comprenden calcitonina. | |
DE3865707D1 (de) | Zusammensetzungen, bestimmt zur holzbehandlung und verfahren zur holzbehandlung. | |
ITTO921027A1 (it) | Procedimento e impianto per disinfettare o sterilizzare i rifiuti. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |